What is LBRX's additional paid-in capital?

LBRX (LBRX) reported additional paid-in capital of $527.06M in Q1 2026.

What does additional paid-in capital mean?

Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.

LBRX LBRX Additional Paid-In Capital

Additional Paid-In Capital at other companies

Bristol-Myers SquibbBMY

$46.37B+0.8%

AlkermesALKS

$3.06B+4.9%

MapLight Therapeutics, Inc. MPLT

$821.9M—

Alto NeuroscienceANRO

$471.22M+61.0%

Zevra Therapeutics, Inc.ZVRA

$602.75M+7.5%

Opko HealthOPK

$3.57B+2.5%

Other financials

Income statement

See full

Net income-$19.1M-259%

EPS (diluted)-$0.67+95.5%

Balance sheet

See full

Cash & equivalents$320.7M—

Total debt$3.5M—

Total equity$378.7M+481%

Total assets$393.5M—

Cash flow

See full

Operating cash flow-$23.3M-187%

CapEx$32.0K+52.4%

Free cash flow-$23.3M-186%

Valuation

See full

Market cap$874.06M+163%

Enterprise value$556.86M—

Returns & leverage

See full

Return on equity-27.9%—

Debt / equity0×—

Current ratio35.7×—

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LBRX's additional paid-in capital?: LBRX (LBRX) reported additional paid-in capital of $527.06M in Q1 2026.
What does additional paid-in capital mean?: Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.